Improving patient outcomes: Mepolizumab’s impact in IL-5-mediated diseases

Improving patient outcomes: Mepolizumab’s impact in IL-5-mediated diseases

The Interleukin-5 (IL-5)-mediated pathogenic role of eosinophils in airway disorders including severe eosinophilic asthma (SEA), chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic granulomatosis with polyangiitis (EGPA), and rare hyper-eosinophilic syndrome (HES) is well established. Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Dipti Gothi, Raghupathi Narasimhan, Randeep Guleria, Manu Chopra, Aanchal Gvalani, Rashmi Hegde
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-05-01
Series:Lung India
Subjects:
crswnp
egpa
eosinophilic asthma
hyper-eosinophilic syndrome hyper-eosinophilia
il-5
mepolizumab
nucala
Online Access:https://journals.lww.com/10.4103/lungindia.lungindia_442_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.lww.com/10.4103/lungindia.lungindia_442_24

Similar Items